AMIODARONE

✓ Medically ReviewedRxClass III Antiarrhythmic⬛ BLACK BOX WARNINGAPPROVED
💡

Quick Summary

Amiodarone is the most potent and broadly effective antiarrhythmic in the clinical arsenal, but it carries a massive burden of cumulative, multi-organ toxicity. It acts primarily as a Class III agent by prolonging the cardiac action potential, while also blocking sodium channels, calcium channels, and beta-receptors. It is uniquely safe in patients with severe structural heart disease and heart failure, where other antiarrhythmics increase mortality. Because of its extreme lipophilicity and half-life measured in months, it requires extensive loading regimens. The dominant clinical challenge is managing its extracardiac risks—specifically pulmonary fibrosis, hepatotoxicity, and profound thyroid dysfunction—which restrict its use to life-threatening ventricular arrhythmias or highly refractory atrial fibrillation.

🔬

Drug Identity

GENERIC NAMEAmiodarone
MEDOBO IDMDBD0017
ATC CODEC01BD01
DRUG CLASSClass III Antiarrhythmic
PHARMACOLOGICAL CLASSPotassium Channel Blocker
THERAPEUTIC CLASSAntiarrhythmic Agent
THERAPEUTIC CATEGORYCardiovascular
CHEMICAL NAME(2-butyl-1-benzofuran-3-yl)-[4-[2-(diethylamino)ethoxy]-3,5-diiodophenyl]methanone hydrochloride
DRUG SOURCESynthetic
FDA APPROVAL1985
MODALITYSmall Molecule
DRUG TYPEstandard
MARKET STATUS● Approved
CORE USE TAGS
AntiarrhythmicVentricular FibrillationAtrial FibrillationRhythm Control
BRAND NAMES (GLOBAL)
CordaronePaceroneNexteroneCordarone XArycorTrangorexAtlansilSedacoronAmiodarAmiocordinRythmarone
SYNONYMS
Amiodarone hydrochlorideL3428L-3428SKF 33134-A
📌

Indications & Uses

🎯 APPROVED INDICATIONS
  • Recurrent ventricular fibrillation (life-threatening) — when refractory to other therapy or when alternative agents are poorly tolerated.
  • Recurrent hemodynamically unstable ventricular tachycardia (life-threatening) — when refractory to other therapy or when alternative agents are poorly tolerated.
🔬 OFF-LABEL USES
  • Atrial Fibrillation (rhythm control) — guideline-supported for maintenance of sinus rhythm, particularly in patients with structural heart disease.
  • Cardiac Arrest — Advanced Cardiovascular Life Support (ACLS) protocol for shock-refractory ventricular fibrillation or pulseless ventricular tachycardia.
  • Supraventricular Tachycardia (SVT) — management of paroxysmal SVT refractory to atrioventricular nodal blocking agents.
MEDICAL DISCLAIMER — This content is intended for educational purposes and qualified healthcare professionals only. Always refer to current prescribing information, institutional protocols, and official clinical guidelines. Medobo is not responsible for clinical decisions made based on this content.